ArticleOncogene2025

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Prahlad V Raninga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.